McElhinney Doff B, Lock James E, Keane John F, Moran Adrian M, Colan Steven D
Department of Cardiology, Children's Hospital, and Harvard Medical School, Boston, Mass 02115, USA.
Circulation. 2005 Feb 1;111(4):451-8. doi: 10.1161/01.CIR.0000153809.88286.2E.
Transcatheter balloon aortic valvuloplasty (BAVP) has become the first-line treatment for critical aortic stenosis (AS) in neonates. However, little is known about the growth and function of left heart structures or about patterns of reintervention on the left heart after neonatal BAVP.
Between 1985 and 2002, 113 patients underwent neonatal BAVP at < or =60 days of age. There were 16 early deaths (14%), with a significant decrease from 1985 to 1993 (22%) to 1994 to 2002 (4%), and 6 patients had successful early conversion to a univentricular circulation. In the short term, the mean relative gradient reduction was 54+/-26%, and significant aortic regurgitation (AR) developed in 15% of patients. The 91 early survivors with a biventricular circulation were followed up for 6.3+/-5.3 years, during which time there was a steady increase in the frequency of significant AR. Freedom from moderate or severe AR was 65% at 5 years. In almost all patients with a baseline aortic annulus z score less than -1, the annulus diameter increased to within the normal range within 1 to 2 years. Similarly, left ventricular (LV) end-diastolic dimension z scores, which ranged from -5 to 7.5 before BAVP, normalized within 1 to 2 years in nearly all patients with a predilation z score less than -1. Among early survivors with a biventricular circulation, reintervention-free survival on the LV outflow tract was 65% at 1 year and 48% at 5 years, with younger age, higher pre- and post-BAVP gradients, and a larger balloon-annulus diameter ratio associated with decreased reintervention-free survival (P<0.01). Seventeen surgical interventions were performed on the aortic valve in 15 patients, including replacement in 7. Survival free from aortic valve replacement was 84% at 5 years.
BAVP for AS during the first 60 days of life results in short-term relief of AS in the majority of patients. Among early survivors, initially small left heart structures may be associated with worse subacute outcomes but typically normalize within 1 year. Reintervention for residual/recurrent AS or iatrogenic AR is relatively common, particularly during the first year after BAVP, but aortic valve replacement during early childhood is seldom necessary.
经导管球囊主动脉瓣成形术(BAVP)已成为新生儿重度主动脉瓣狭窄(AS)的一线治疗方法。然而,对于左心结构的生长和功能,以及新生儿BAVP后左心再次干预的模式,我们知之甚少。
1985年至2002年期间,113例年龄≤60天的患者接受了新生儿BAVP。有16例早期死亡(14%),从1985年至1993年的22%显著下降至1994年至2002年的4%,6例患者成功早期转变为单心室循环。短期内,平均相对梯度降低54±26%,15%的患者出现显著主动脉瓣反流(AR)。91例双心室循环的早期幸存者随访了6.3±5.3年,在此期间,显著AR的发生率稳步上升。5年时无中度或重度AR的比例为65%。几乎所有基线主动脉瓣环z值小于-1的患者,瓣环直径在1至2年内增加至正常范围内。同样,左心室(LV)舒张末期内径z值在BAVP前范围为-5至7.5,几乎所有扩张前z值小于-1的患者在1至2年内恢复正常。在双心室循环的早期幸存者中,左心室流出道无再次干预生存1年时为65%,5年时为48%,年龄较小、BAVP前后梯度较高以及球囊-瓣环直径比更大与无再次干预生存降低相关(P<0.01)。15例患者对主动脉瓣进行了17次手术干预,其中7例进行了置换。5年时无主动脉瓣置换生存为84%。
出生后60天内对AS进行BAVP可使大多数患者在短期内缓解AS。在早期幸存者中,最初较小的左心结构可能与较差的亚急性结局相关,但通常在1年内恢复正常。对残余/复发性AS或医源性AR进行再次干预相对常见,尤其是在BAVP后的第一年,但幼儿期很少需要进行主动脉瓣置换。